Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      La Roche-Posay Celebrates their 40th Anniversary!

      Leading Dermatological Skincare Brand, La Roche-Posay, Celebrates 40 Years of Worldwide Success


      News provided by

      La Roche-Posay

      Dec 11, 2015, 10:03 ET

      Share this article

      Share this article


      NEW YORK, Dec. 11, 2015 /PRNewswire/ -- For 40 years, La Roche-Posay has been a trusted source for skincare worldwide. Rooted in a commitment to dermatology, La Roche-Posay remains the top European dermatological thermal center, treating multiple skin conditions, and has been developing safe and efficient skincare products that adhere to dermatologist standards since 1975.

      At the heart of the brand and in most of the products is the Thermal Spring Water, which dates back to the 14th century. In the French town of La Roche-Posay lies a unique thermal spring, enriched with minerals and antioxidants that proved to be soothing to the skin. The La Roche-Posay Dermatological Thermal Center opened in 1905 to take advantage of the springs' long-standing healing properties. Since its inception, more than 400,000 adults and children have received treatment, making it the top European dermatological thermal center for conditions such as eczema, psoriasis, burning wounds, and most recently, post-cancer treatments. The hospital continues to treat approximately 8,000 patients each year, and also offers educational workshops for skin cancer awareness, children with atopy, and those undergoing oncology treatments to help improve quality of life.  

      Realizing the need for adjunctive therapy; products that are recommended by dermatologist to offer benefits that compliment treatments, in 1975 La Roche-Posay first formulated products using the proprietary thermal spring water that could be used at home. La Roche-Posay also follows a strict formulation charter and ensures that every product is allergy tested and safe for all skin types. The brand made its way into the U.S. in 1999, being sold exclusively in dermatologists' offices, creating a worldwide partnership. Commitment to Dermatology was furthered with the creation of La Fondation La Roche-Posay which gives annual grants, the latest being Dermatologist from the Heart Program.

      The Dermatologist from the Heart Program encourages dermatological research in the fields of clinical medicine, biology and pharmacology. La Fondation La Roche-Posay Research Grant Program began awarding one grant winner annually to build and execute an innovative program that benefits the entire skincare community. La Fondation La Roche-Posay as a whole has awarded over 100 grants for dermatology research and their various skincare programs.

      In addition to research grants, La Roche-Posay's commitment to dermatology raises awareness for skin cancer with the Women's Dermatologic Society. Through SOS – Save our Skin Campaign, free skin cancer screenings are offered each year to the public along with sun safe behavior information and Anthelios sunscreen samples. A European leader in sunscreen, La Roche-Posay is known for advanced UVA/UVB sunscreen protection plus antioxidants in revolutionary textures that break industry standards. In 2006, Anthelios SX was the first FDA approved filter in a sunscreen formula in over 20 years. Today, Anthelios is recommended by dermatologists, consumers and independent groups like Consumer Reports – Anthelios 60 Melt-in Sunscreen Milk was the only sunscreen to receive a perfect score from the 2015 Consumer Reports Annual Sunscreen Test.

      Not only does La Roche-Posay focus on sun care, but also developing innovative formulas for sensitive, mature and acne prone skin. Furthermore, this year alone La Roche-Posay was granted 13 Awards for groundbreaking products including Anthelios AOX, Effaclar Dermatological 3-Step Acne System, Micellar Water Cleansing Solution, Pigmentclar Serum and Effaclar BB Blur, amongst others.

      To help celebrate the 40-year milestone, La Roche-Posay is offering an Anniversary Kit, which includes the best-selling products and fan favorites – travel-sized samples of Effaclar BB Blur, Effaclar Purifying Foaming Gel Cleanser, Thermal Spring Water, Redermic [R] Intensive Anti-Aging Corrective Treatment and Anthelios 60 Ultra-Light Sunscreen Fluid. This limited edition is available exclusively online at LaRoche-Posay.us for one month starting on December 15th – January 15th for $15.00.

      La Roche-Posay has committed 40 years to pioneering and focusing on building a better life for sensitive skin, and will continue as the leading dermatological skincare brand worldwide.

      For additional information about La Roche-Posay, visit www.laroche-posay.us and "like" the La Roche-Posay Facebook page at www.facebook.com/LaRochePosayusa.

      About LA ROCHE-POSAY and ANTHELIOS
      Recommended by more than 25,000 dermatologists worldwide, La Roche-Posay offers a unique range of daily skincare developed with dermatologists to meet their standards in efficacy, tolerance and elegant textures for increased compliance. The products, which are developed using a strict formulation charter, include a minimal number of ingredients to reduce side effects and reactivity and are formulated with active ingredients at optimal concentrations for increased efficacy. Additionally, La Roche-Posay products undergo stringent clinical testing to guarantee efficacy and safety, even on sensitive skin. A leader in advanced UVA formulation research and innovation for over 15 years, La Roche-Posay's Anthelios sunscreen range is trusted and recognized by dermatologists all over the world for providing effective UVA and UVB protection. The range features advanced patented sunscreen technologies, including 100% mineral-based UV protection formulas, as well as those developed with Mexoryl™SX, a unique, key ingredient that acts as a short wave UVA filter, and most recently, CELL-OX SHIELD™ XL, a powerful, synergistic combination of filters that provides UVA/UVB and antioxidant protection using 21% fewer ingredients. All Anthelios sunscreens are known for their effective, broad-spectrum protection as well as their fast-absorbing, lightweight and cosmetically elegant texture.

      About SOS – Save Our Skin
      Now in its sixth year, La Roche-Posay continues its SOS – Save Our Skin to not only inform Americans about the dangers of UV rays and the importance of sun safety, but to also encourage true behavioral change, such as incorporating sun protection in their daily routines and visiting their dermatologists for regular skin checks. In partnership with the Women's Dermatologic Society (WDS), the SOS – Save Our Skin campaign lives through a series of initiatives, including skin checks at sporting events, local hospitals and drug stores as well as free skin checks offered to all L'Oreal corporate employees. To learn how to do a self-check and choose the right protection, visit www.sossaveourskin.com.               

      About the WDS
      The Women's Dermatologic Society, founded in 1973, is dedicated to helping dermatologists fulfill their greatest potential and assisting them in making a contribution to the specialty and society. To achieve this goal, the Society relies on the active participation of its members, who represent a diverse cross-section of professional subspecialties. The mission of the Women's Dermatologic Society is to support dermatologists by striving to: promote leadership and the development of relationships through mentoring and networking; demonstrate a commitment to service through community outreach and volunteerism; provide a forum for communications and research relevant to women's and family issues; advocate excellence in patient care and education, and promote the highest ethical standards. www.playsafeinthesun.org and www.womensderm.org

      About the Dermatologist from the Heart Program
      Committed to working alongside dermatologists, La Roche-Posay created its namesake foundation in 1995 to encourage dermatological research in the fields of clinical medicine, biology and pharmacology. The Dermatologist from the Heart program is the latest initiative to join the La Fondation La Roche-Posay's several other global community-oriented programs, which include the Atopy Schools initiative that helps atopic dermatitis patients and their families face the challenges of the disease, as well as the Corrective Make-Up Workshops, which are devoted to instilling self-confidence in patients suffering from skin lesions.

      SOURCE La Roche-Posay

      Modal title

      Also from this source

      GLOBAL STREAMERS TURN WORLD GAMING DAY INTO A GLOBAL FIGHT FOR CANCER SUPPORT WITH LA ROCHE-POSAY USA ON DISCORD

      GLOBAL STREAMERS TURN WORLD GAMING DAY INTO A GLOBAL FIGHT FOR CANCER SUPPORT WITH LA ROCHE-POSAY USA ON DISCORD

      During World Gaming Day today, La Roche-Posay will host a new edition of its Gaming For Cause livestream campaign where top gamer Tyler "Ninja"...

      La Roche-Posay Introduces Anthelios UV Defense SPF 50 Featuring BEMT, The First Sun Filter Approved by the FDA in Over 25 Years

      La Roche-Posay Introduces Anthelios UV Defense SPF 50 Featuring BEMT, The First Sun Filter Approved by the FDA in Over 25 Years

      La Roche-Posay introduces Anthelios UV Defense SPF 50 Sunscreen, featuring Bemotrizinol (BEMT), the first UV filter approved by the FDA in over 25...

      More Releases From This Source

      Explore

      Household, Consumer & Cosmetics

      Household, Consumer & Cosmetics

      Cosmetics and Personal Care

      Cosmetics and Personal Care

      New Products & Services

      New Products & Services

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.